Low calcium after thyroid removal
Official title: A Ten-Year Cohort Study of Clinical and Surgical Predictors for Hypocalcemia Post-Thyroidectomy
Run by Minia University · NCT07428057 · Data updated 2026-11-12
This project will see if clinical, lab, and surgical factors predict low calcium after thyroid surgery in adults treated at Minia University Hospital from 2014–2024.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Minia University Academic / other |
| Drugs / interventions | denosumab |
| Locations | 1 site (Minya, Minya Governorate) |
| Status | Recruiting |
| Started | January 1, 2014 |
| Main results expected | December 1, 2026 |
| Study ends | January 1, 2027 |
| Registry record updated | September 22, 2026 |
| Trial ID | NCT07428057 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (age ≥18) who underwent thyroidectomy at Minia University Hospital between 2014 and 2024 with complete surgical and postoperative records, documented postoperative calcium levels, and at least 6 months of follow-up or a documented outcome.
✕Probably not a fit
Patients under 18, those with preexisting parathyroid disorders, chronic kidney disease stage 3 or higher, malabsorption syndromes, prior neck irradiation, concurrent planned parathyroidectomy, chronic medications that strongly affect calcium metabolism, or incomplete records are excluded and unlikely to benefit from this analysis.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center retrospective cohort review of all adults who underwent total, subtotal, or completion thyroidectomy at Minia University Hospital between January 1, 2014 and December 31, 2024. Investigators will extract demographics, preoperative labs (calcium, vitamin D, PTH, thyroid tests), surgical details (extent of surgery, lymph node dissection, surgeon experience, operative time, parathyroid identification/autotransplantation), postoperative calcium/PTH measurements, supplementation needs, and pathology findings. Univariate analyses will screen potential predictors and multivariable logistic regression will be used to identify independent risk factors for transient and permanent postoperative hypocalcemia. The goal is to generate local risk stratification data to guide perioperative management and patient counseling.
Why it matters
Potential benefit: If successful, the findings could help clinicians identify patients at higher risk for post-thyroidectomy low calcium and tailor monitoring and supplementation to reduce symptoms and the chance of permanent hypocalcemia.
How similar studies have gone: Previous retrospective and some prospective studies have identified risk factors for post-thyroidectomy hypocalcemia, so this study mainly provides confirmatory and locally relevant data rather than a novel treatment approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients aged 18 years or older at time of surgery * Underwent thyroidectomy at Minia University Hospital * Availability of medical records with complete surgical and postoperative data * Documented serum calcium levels measured postoperatively * Minimum follow-up of 6 months postoperatively or documented outcome status Exclusion Criteria: * Age less than 18 years at time of surgery * Preoperative hypocalcemia (serum calcium \<8.0 mg/dL or ionized calcium \<1.0 mmol/L) * Pre-existing parathyroid disorders (primary hyperparathyroidism, hypoparathyroidism, secondary or tertiary hyperparathyroidism) * Chronic kidney disease Stage 3 or higher (estimated glomerular filtration rate \<60 mL/min/1.73m²) * Malabsorption syndromes affecting calcium metabolism (celiac disease, inflammatory bowel disease,short bowel syndrome) * Concurrent planned parathyroidectomy * History of neck irradiation * Chronic use of medications significantly affecting calcium metabolism (bisphosphonates, denosumab,cinacalcet, chronic corticosteroids) * Incomplete medical records lacking essential data including surgical details, postoperative calcium levels,or follow-up data * Patients lost to follow-up before 6-month endpoint without documented outcome status
Where it's running
-
Minia University Hospital
Minya, Minya Governorate, Egypt Recruiting
Study contacts
- Principal investigator: Saleh K Saleh, MD — Minia University
- Study coordinator: Saleh K Saleh, MD
- Email: salehkhairy@mu.edu.eg
- Phone: 01201765401
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
NIRAF-guided identification of parathyroids during thyroidectomy
A wearable near-infrared autofluorescence device is being tested to help surgeons find and protect the parathyroid glands during thyroid surgery in adults.
-
Active monitoring for small Bethesda IV thyroid nodules
This program will try active monitoring with scheduled ultrasounds and clinic visits instead of immediate surgery for adults with a single Bethesda IV thyroid nodule under 2 cm.
-
Using radiofrequency ablation to treat low-risk thyroid cancer
This study is testing if a new treatment called radiofrequency ablation can safely help people with low-risk thyroid cancer that is 2 cm or smaller instead of traditional surgery.
-
Improving prediction for challenging thyroid surgeries
This study is testing a new way to predict how challenging thyroid surgeries will be by looking at different health factors to help doctors perform the surgery better.
-
Developing a scoring tool for robotic thyroid surgery performance
This study is trying to create a scoring tool to help doctors measure how well they perform robotic thyroid surgeries, with the aim of improving patient care.
-
Immediate biopsy versus active ultrasound monitoring for suspicious thyroid nodules
This will try immediate biopsy versus careful ultrasound monitoring to see which causes less anxiety and better thyroid-related quality of life for adults with newly found suspicious thyroid nodules (TI‑RADS 4–5) that are 2 cm or smaller.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.